WGCNA of the sample characteristics and proteins of the two oat varieties under drought stress. حسب Caijin Chen (3107787)

الموضوعات:

Changes in the growth of two oat varieties under drought stress and normal water supply treatments. حسب Caijin Chen (3107787)

الموضوعات:

Child mortality rate per 1,000 person-years during the 18-month follow-up period. حسب Samuel Sendagala (21417164)

الموضوعات:

Volcano map of DAPs. حسب Caijin Chen (3107787)

الموضوعات:

KEGG pathway enrichment bubble map of the top 20 DAPs. حسب Caijin Chen (3107787)

الموضوعات:

Normalized sample plots for each treatment for data quality control. حسب Caijin Chen (3107787)

الموضوعات:

Basic physical and chemical properties of the soils. حسب Caijin Chen (3107787)

الموضوعات:

Kaplan–Meier cumulative survival curve for infants exposed and not exposed to HIV. حسب Samuel Sendagala (21417164)

الموضوعات:

Mortality dataset used in analysis. حسب Samuel Sendagala (21417164)

الموضوعات:

Different responses of two oat varieties to drought stress. حسب Caijin Chen (3107787)

الموضوعات:

GO enrichment of DAPs, including BP, CC, and MF. حسب Caijin Chen (3107787)

الموضوعات:

Optimization of Linear Loading Strategy for Fuel Cell Initiation Based on Gaussian Process Regression Model (Supporting Information) حسب Jianbin SU (19730371)

Data Sheet 1_Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greate... حسب Ayman Alhejazi (21092054)

"…Background<p>Multiple myeloma (MM) is a plasma cell malignancy with significant unmet medical needs, particularly in the treatment of relapsed and refractory disease. …"

AZ10606120 treatment significantly increased cytotoxicity and reduced cell number in a dose-dependent manner. حسب Matthew Drill (22258391)

"…Cell numbers were significantly decreased in cells after treatment with AZ10606120 (50µM) compared to both temozolomide (TMZ; 50µM) treatment and untreated controls. …"

Study selection criteria. حسب Filip Stanicic (17808254)

"…Phase II/III trials consistently reported significantly greater CAPS improvement with MDMA-AT vs. placebo with therapy (PT) after two or three interventional sessions. …"

PICOS criteria for the SLR. حسب Filip Stanicic (17808254)

"…Phase II/III trials consistently reported significantly greater CAPS improvement with MDMA-AT vs. placebo with therapy (PT) after two or three interventional sessions. …"

PRISMA flow chart. حسب Filip Stanicic (17808254)

"…Phase II/III trials consistently reported significantly greater CAPS improvement with MDMA-AT vs. placebo with therapy (PT) after two or three interventional sessions. …"

Changes in relative abundance of genera in both therapeutic groups. حسب Flavia Furlaneto (20161022)

Mean muscle activation patterns across the gait cycle during walking with mediolateral (ML) forces for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke duri... حسب Sanne Ettema (18786312)

Mean muscle activation patterns across the gait cycle during walking with anteroposterior (AP) forces for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke d... حسب Sanne Ettema (18786312)